Compare Sanofi SA (SNY) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sanofi SA vs Tempus AI — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Tempus AI trades at $49.05 (market cap $8.69B). The key difference: Sanofi SA is far larger — about 12.1× Tempus AI's market cap, and Sanofi SA pays a 5.5% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| SNY | TEM | |
|---|---|---|
Market Cap | $104.83B | $8.69B |
Sector | Health | Broad Market / Factor |
52-Week High | $52.34 | $103.25 |
52-Week Low | $41.33 | $42.37 |
Enterprise Value | $121.32B | $9.37B |
Dividend Yield | 5.5% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
